 Pfenex Inc. NYSE American: PFNX announced today the achievement of several significant milestones across their business portfolio. Theramex, the European commercialization partner for Pfenex and Adalvo formerly Alvogen B2B, received a positive opinion for PF708 branded in Europe as LivogivaTM from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA. 